MRNA

Moderna, Inc. (MRNA)

Last Price$35.55.3%

Market Cap$13.7B

LTM Return on Equity (ROE)

(21.4%)

5Y avg

11.8%

Biotechnology industry median

(52.8%)

Stock quality & Intrinsic value

6/10

0.9% undervalued

is 90.7% undervalued

undervalued stocks

Start beating the S&P 500

Moderna, Inc. Return on Equity (ROE)

Annual

Quarterly

LTM

Industry median

Company stand-alone

MRNA

Healthcare

Crunching data... Almost there!

	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23
Return on Equity (ROE)	(25.7%)	(34.9%)	(35.7%)	(38.0%)	(40.0%)	146.1%	50.3%	(28.6%)

MRNA

Key metrics and insights to make informed decisions.

View full analysis

Overvalued or undervalued?

Check the intrinsic value for MRNA and see if it's the right time to invest.

Moderna, Inc. (MRNA) Return on Equity (ROE) comparison analysis

Crunching data... Almost there!

MRNA key stats

USD

Millions

Billions

Annual

Quarterly

Trailing

Key stats

Income statement

Balance sheet

Cash Flow Statement

Valuation

Ratios

Per share

Per employee

Dividends & Yields

Crunching data... Almost there!

Discover more Stock Ideas

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

FAQ

1) What is Moderna, Inc.'s Return on Equity (ROE)?

As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is (21.4%), based on the financial report for Dec 31, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Moderna, Inc. have been 25.1% over the past three years, and 12.4% over the past five years.

2) Is Moderna, Inc.'s Return on Equity (ROE) Good?

As of today, Moderna, Inc.'s Return on Equity (ROE) is (21.4%), which is higher than industry median of (52.8%). It indicates that Moderna, Inc.'s Return on Equity (ROE) is Good.

3) How does Moderna, Inc.'s Return on Equity (ROE) compare to its peers?

As of today, Moderna, Inc.'s Return on Equity (ROE) is (21.4%), which is lower than peer median of (2.5%). The list of peers includes NVO, UTHR, REGN, INCY, BNTX, VRTX, ARGX, BGNE, SMMT, ALNY.